Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Evogene (EVGN) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Evogene (EVGN) over the last 14 years, with Q3 2025 value amounting to $378000.0.

  • Evogene's Other Operating Expenses fell 2730.77% to $378000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 4825.14%. This contributed to the annual value of $2.5 million for FY2024, which is 3085.02% down from last year.
  • As of Q3 2025, Evogene's Other Operating Expenses stood at $378000.0, which was down 2730.77% from $412000.0 recorded in Q2 2025.
  • In the past 5 years, Evogene's Other Operating Expenses ranged from a high of $1.5 million in Q1 2024 and a low of -$2.3 million during Q4 2022
  • For the 5-year period, Evogene's Other Operating Expenses averaged around $594894.7, with its median value being $720000.0 (2021).
  • In the last 5 years, Evogene's Other Operating Expenses tumbled by 42388.89% in 2022 and then surged by 14429.67% in 2023.
  • Over the past 5 years, Evogene's Other Operating Expenses (Quarter) stood at $720000.0 in 2021, then plummeted by 423.89% to -$2.3 million in 2022, then soared by 144.3% to $1.0 million in 2023, then plummeted by 37.08% to $650000.0 in 2024, then plummeted by 41.85% to $378000.0 in 2025.
  • Its last three reported values are $378000.0 in Q3 2025, $412000.0 for Q2 2025, and $454000.0 during Q1 2025.